205TiP ATRACTIB: A phase II trial of first-line (1L) atezolizumab (A) in combination with paclitaxel (P) and bevacizumab (B) in metastatic triple-negative breast cancer (mTNBC)
Cortés Salgado, A., Perez Garcia, J.M., Cortez Castedo, S.P., Gion Cortes, M., Morales Murillo, S., Blancas López-Barajas, I., Blanch, S., Calvo Plaza, I., Diaz Fernandez, N., Marmé, F., Martinez Bueno, A., Taberner Bonastre, M.T., De Laurentiis, M., Ruiz Borrego, M., Schmid, P., Guarneri, V., Gligorov, J., Sampayo-Cordero, M., Llombart Cussac, A., Cortés, J.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
17P Prognostic and predictive non-invasive biomarkers in early triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT)
Abad, M. Nunez, Torres-Martínez, S., Mosqueda-Frometa, M., Taberner-Bonastre, M.T., García, J.Á. García, Ben Hammou El Majdoubi, F., Lewintre, E. Jantus, Herrero, C. Camps, Iranzo, V., Fariñas, S. Calabuig
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article